Recombinant Rat C-type lectin domain family 4 member F (Clec4f)

What is Clec4f and what are its alternative names in scientific literature?

Clec4f, also known as Kupffer Cell Receptor (KCR), is a C-type lectin domain family member first purified from rat liver extract. It is also referred to as Clecsf13 in scientific literature. This membrane protein is exclusively expressed on Kupffer cells, the resident macrophages of the liver, and shows high binding affinity to specific carbohydrate structures . Unlike many other immune receptors, Clec4f is notably absent in humans, making it a species-specific receptor of interest in comparative immunology studies .

What is the molecular structure of rat Clec4f?

Rat Clec4f is a heavily glycosylated membrane protein with a characteristic structure of C-type lectins. Based on crystallographic data, mouse Clec4f (which shares high homology with rat Clec4f) forms a trimeric structure with unique features . The protein contains:

• A carbohydrate-recognition domain (CRD)

• A neck region

• A transmembrane domain

The crystal structure reveals an unusual orientation between the CRD and neck region, resulting in a distance of approximately 45 Å between glycan-binding sites within the Clec4f trimer . The trimeric coiled-coil interface within its heptad neck region contains multiple polyglutamine interactions instead of the predominantly hydrophobic leucine zipper found in other C-type lectin receptors, representing a unique structural feature .

What carbohydrate structures does Clec4f recognize and bind to?

Rat Clec4f demonstrates specific carbohydrate binding preferences with high affinity for:

The receptor also recognizes desialylated complex N-linked glycans and specific glycolipids, including:

• Gb4Cer (GalNAcβ1-3Galα1-4Galβ1-4GlcβlCer)

• Gb5Cer (GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4GlcβlCer)

• LacCer (Galβ1-4GlcβlCer)

This binding activity is calcium-dependent, as demonstrated by inhibition studies where both galactose and ceramide can partially inhibit Clec4f binding to α-galactoceramide .

How does Clec4f binding specificity differ from other C-type lectins?

Clec4f binding specificity distinguishes it from other C-type lectins through its unique preference for both terminal galactose and N-acetylgalactosamine residues. Unlike many C-type lectins that recognize either mannose-type or galactose-type carbohydrates, Clec4f demonstrates high affinity for both fucose and galactose-terminated structures .

The structural basis for this binding specificity appears to be related to its unique trimeric assembly, which creates a distinct spatial arrangement of binding sites compared to other C-type lectins. The observed distance of 45 Å between glycan-binding sites within the Clec4f trimer may facilitate multivalent interactions with complex carbohydrate structures . Additionally, while many C-type lectins function in diverse tissues, Clec4f's highly restricted expression to Kupffer cells suggests a specialized role in hepatic immune surveillance .

What is the role of Clec4f in glycolipid antigen presentation to NKT cells?

Clec4f plays a critical role in the presentation of glycolipid antigens, particularly α-galactoceramide (α-GalCer), to Natural Killer T (NKT) cells. Studies using Clec4f-deficient mice have demonstrated that these knockout animals produce significantly fewer cytokines than wild-type littermates following intravenous injection of α-GalCer .

The mechanism appears to involve:

• Clec4f binding to α-GalCer in a calcium-dependent manner

• Facilitated presentation of the glycolipid to CD1d molecules

• Enhanced recognition by NKT cells

• Subsequent cytokine production

This function highlights Clec4f's importance not just as a marker for Kupffer cells but as an active participant in immune responses within the liver microenvironment . The specialized role in glycolipid antigen presentation may explain the evolutionary conservation of this receptor in rodents despite its absence in humans.

How does Clec4f expression change during liver inflammation and infection?

During liver inflammation and infection, Clec4f expression demonstrates interesting dynamics. Upon infection with Listeria monocytogenes, both residential Kupffer cells and infiltrating mononuclear cells surrounding liver abscesses become CLEC4F-positive . This suggests that Clec4f expression can be induced in certain inflammatory contexts.

What are the recommended approaches for detecting Clec4f expression in tissue samples?

For detecting Clec4f expression in tissue samples, several validated methodologies are recommended:

• Immunohistochemistry/Immunofluorescence:

  • Use monoclonal antibodies specific to murine Clec4f

  • Co-staining with F4/80 to confirm Kupffer cell identity

  • Perform on fresh-frozen liver sections for optimal epitope preservation

• Flow Cytometry:

  • Use anti-Clec4f monoclonal antibodies verified by binding to 293T cells transfected with Clec4f cDNA

  • Include proper controls using Clec4f-deficient mice tissues

  • Combine with F4/80 and other macrophage markers for cell population analysis

• RT-PCR and qPCR:

  • Design primers specific to Clec4f coding sequence

  • Include liver tissue as positive control

  • Use other tissues (spleen, lymph nodes) as negative controls

When analyzing embryonic tissues, special attention should be paid to developmental timing, as Clec4f is detectable from E11.5 in the developing liver but absent in yolk sac cells .

What strategies are effective for producing recombinant Clec4f for binding studies?

For producing functional recombinant Clec4f for binding studies, the following strategies have proven effective:

• Expression Systems:

  • Mammalian expression systems (HEK293T cells) are preferred due to the requirement for proper glycosylation

  • Construct design should consider the heavily glycosylated nature of Clec4f

• Fusion Proteins:

  • Clec4f.Fc fusion proteins (joining the extracellular domain to an Fc fragment) have been successfully used for binding studies

  • These constructs retain calcium-dependent binding to α-galactoceramide

• Purification Approaches:

  • Affinity chromatography using fucose-BSA-Sepharose columns

  • Calcium-dependent elution strategies to maintain protein functionality

• Verification of Functionality:

  • Calcium-dependent binding assays

  • Glycan array screening to confirm binding specificity

  • Testing inhibition with galactose and ceramide moieties

For structural studies, expression of the carbohydrate recognition domain alone or with minimal neck region has been successful in producing protein for crystallography .

How can Clec4f knockout models be utilized to study Kupffer cell functions?

Clec4f knockout (Clec4f^-/-) mice provide valuable tools for investigating Kupffer cell functions, particularly in relation to glycolipid antigen presentation and liver-specific immune responses. These models can be utilized in several ways:

• Glycolipid Antigen Presentation Studies:

  • Compare cytokine production following α-GalCer administration between knockout and wild-type mice

  • Analyze NKT cell activation patterns in the absence of Clec4f

  • Measure differences in presented antigen repertoire

• Liver Infection Models:

  • Challenge with Listeria monocytogenes to assess differences in bacterial clearance

  • Evaluate immune cell recruitment to infection sites

  • Monitor liver damage markers in the absence of Clec4f-mediated responses

• Kupffer Cell Development Analysis:

  • Assess whether Clec4f deficiency affects Kupffer cell development or maturation

  • Compare F4/80+ cell populations and their distribution in the liver

• Comparative Immunology:

  • Investigate how Kupffer cells compensate for Clec4f absence through potential upregulation of other pattern recognition receptors

  • Study whether human Kupffer cells utilize alternative mechanisms for functions performed by Clec4f in rodents

These knockout models provide critical insights into the specialized functions of liver-resident macrophages and their role in hepatic immunity.

What approaches are recommended for studying Clec4f-mediated endocytosis mechanisms?

Studying Clec4f-mediated endocytosis requires specialized approaches to track both receptor and ligand trafficking. The following methods are recommended:

• Fluorescently-Labeled Ligands:

  • Prepare α-GalCer or other Clec4f ligands tagged with fluorescent dyes

  • Track uptake using confocal microscopy or flow cytometry

  • Compare uptake kinetics in Clec4f-expressing cells versus controls

• Receptor Trafficking Analysis:

  • Generate tagged Clec4f constructs (e.g., GFP-Clec4f fusion proteins)

  • Use live cell imaging to monitor receptor internalization and recycling

  • Co-localize with endosomal markers to determine trafficking pathways

• Endocytosis Inhibition Studies:

  • Use specific inhibitors of clathrin-dependent or -independent endocytosis

  • Compare effects on Clec4f-mediated uptake of ligands

  • Evaluate whether calcium chelation affects endocytosis versus binding

• Structure-Function Analysis:

  • Create truncated or mutated Clec4f constructs to identify domains critical for endocytosis

  • Focus on motifs in cytoplasmic regions that might interact with endocytic machinery

These approaches can help elucidate whether Clec4f primarily functions in recognition and binding or actively participates in clearance of specific glycan structures through endocytosis, similar to the asialoglycoprotein receptor.

What are the key structural features that distinguish Clec4f from other C-type lectins?

Clec4f displays several distinctive structural features that set it apart from other C-type lectins:

• Trimeric Assembly:

  • Forms a trimer with an unusual orientation between the carbohydrate-recognition domain (CRD) and neck region

  • Creates approximately 45 Å distance between glycan-binding sites within the trimer

• Unique Coiled-Coil Interface:

  • Contains multiple polyglutamine interactions in the heptad neck region

  • Differs from the predominantly hydrophobic leucine zipper found in other C-type lectin receptors

• Calcium-Binding Sites:

  • Contains two calcium ions and one water molecule per monomer

  • These calcium-binding sites are critical for carbohydrate recognition

• Carbohydrate Recognition Domain:

  • Specific structural features enable binding to both fucose and galactose-terminated glycans

  • Recognizes α-galactoceramide in a calcium-dependent manner

The crystal structure of mouse Clec4f (which shares high homology with rat Clec4f) includes residues from 393 to 543, providing detailed insights into the receptor's glycan recognition mechanisms . These structural distinctions likely contribute to Clec4f's specialized function in Kupffer cells.

How can researchers investigate the structure-function relationship of Clec4f using recombinant expression systems?

Investigating the structure-function relationship of Clec4f using recombinant expression systems requires careful experimental design:

• Domain-Specific Constructs:

  • Generate constructs expressing full-length Clec4f, CRD-only, and neck-CRD regions

  • Compare binding properties of each construct using glycan arrays or surface plasmon resonance

  • Assess trimerization capabilities of different constructs

• Site-Directed Mutagenesis:

  • Target calcium-binding residues to confirm their role in carbohydrate recognition

  • Modify polyglutamine regions in the neck domain to assess their role in trimerization

  • Create chimeric constructs with neck regions from other C-type lectins to evaluate domain swapping effects

• Calcium Dependence Studies:

  • Use microscale thermophoresis to measure binding affinities under varying calcium concentrations

  • Compare wild-type and mutant constructs for calcium sensitivity in binding assays

• Structural Analysis:

  • Employ X-ray crystallography for high-resolution structural determination

  • Use small-angle X-ray scattering (SAXS) to analyze the solution structure of the trimeric assembly

  • Apply molecular dynamics simulations to predict the effects of mutations

These approaches can elucidate the molecular basis for Clec4f's unique binding properties and assembly, providing insights into its specialized role in Kupffer cell biology.

What are the implications of studying rat Clec4f given its absence in humans?

The absence of a direct ortholog of Clec4f in humans presents both challenges and opportunities for translational research:

• Comparative Immunology:

  • Investigating rat Clec4f provides insights into species-specific adaptations in innate immunity

  • Understanding how human Kupffer cells compensate for the absence of Clec4f may reveal alternative mechanisms for glycolipid recognition

  • The species-specific nature of Clec4f highlights the importance of cautious interpretation when extrapolating rodent liver immunology findings to humans

• Evolutionary Biology:

  • Studying why Clec4f was maintained in rodents but lost in humans may reveal selective pressures and evolutionary adaptations

  • Comparing the glycan recognition systems between species can illuminate divergent strategies for pathogen recognition

• Rodent Models of Human Disease:

  • Researchers must consider the absence of Clec4f when using rat models for human liver diseases

  • Recognition of this difference is crucial when evaluating glycolipid-based therapeutics in rodent models

While direct translational applications may be limited by the absence of Clec4f in humans, studying this receptor provides valuable insights into the principles of C-type lectin biology and species-specific adaptations in innate immunity.

How can Clec4f research inform our understanding of liver-specific immune responses?

Despite its absence in humans, research on Clec4f offers several important insights into liver-specific immune responses that may have broader implications:

• Kupffer Cell Biology:

  • Clec4f serves as a specific marker for Kupffer cells, enabling precise identification and isolation of these cells from other liver macrophage populations

  • Understanding Clec4f regulation can reveal mechanisms controlling Kupffer cell development and specialization

• Glycolipid Antigen Presentation:

  • The role of Clec4f in presenting α-galactoceramide to NKT cells highlights specialized pathways for glycolipid antigen processing in the liver

  • This may inform broader understanding of how various glycolipid antigens are presented in different tissues

• Liver Inflammation Mechanisms:

  • The induction of Clec4f in inflammatory contexts provides insights into how liver-resident macrophages respond to infection

  • This may reveal conserved signaling pathways that are also relevant to human Kupffer cells

• Therapeutic Target Identification:

  • While Clec4f itself is not a target in humans, understanding its binding mechanisms and downstream signaling may identify conserved pathways that could serve as therapeutic targets

By studying the specialized functions of this receptor in rodents, researchers can gain insights into the broader principles of liver immunology that may have parallels in human biology, even in the absence of the specific receptor itself.